Chitosan-coated alginate microspheres for embolization and/or chemoembolization:: In vivo studies

被引:18
作者
Eroglu, Muzaffer
Kursaklioglu, Hurkan
Misirli, Yasemin
Iyisoy, Atilla
Acar, Abuzer
Dogan, A. Isin
Denkbas, Emir B. [1 ]
机构
[1] Hacettepe Univ, Dept Chem, Div Biochem, TR-06800 Ankara, Turkey
[2] Gulhane Mil Med Acad, Dept Cardiol, Ankara, Turkey
[3] SSK Ihtisas Hosp, Dept Urol, Ankara, Turkey
[4] Afyon Kocatepe Univ, Fac Vet, Afyon, Turkey
[5] Yeditepe Univ, Fac Med, Dept Pathol, Istanbul, Turkey
关键词
embolization; chemoembolization; alginate; chitosan; microsphere;
D O I
10.1080/02652040500286318
中图分类号
O69 [应用化学];
学科分类号
081704 ;
摘要
In this study, chitosan-coated alginate microspheres were prepared by the ionic complexation of alginate and chitosan biopolymers to use in embolization and/or chemoembolization studies. Biopolymeric microspheres were prepared by the ionic gelation technique of alginate with a suitable divalent cation (i.e. CaCl2) in a suspension medium composed of mineral oil and petroleum ether including emulsifier (i.e. Tween-80) and then obtained microspheres were coated with chitosan in an aqueous chitosan solution while the medium was magnetically stirred. The obtained microspheres are in the size range of 100-400 mu m and they can be prepared as required by changing the preparation conditions (i.e. stirring rate, concentration of biopolymers, molecular weight and concentration of chitosan, etc.). In the in vivo studies, New Zealand rabbits were used as the test animals. Both complete and partial embolization of the kidney were achieved by using the microspheres. The renal angiograms obtained before/after embolization and the histopathological observations showed the feasibility of the chitosan-coated alginate microspheres as an alternative embolization and/or chemoembolization agent.
引用
收藏
页码:367 / 376
页数:10
相关论文
共 20 条
[1]  
[Anonymous], 1995, P INT S CONTR REL BI
[2]   Oral vaccination with alginate microsphere systems [J].
Bowersock, TL ;
HogenEsch, H ;
Suckow, M ;
Porter, RE ;
Jackson, R ;
Park, H ;
Park, K .
JOURNAL OF CONTROLLED RELEASE, 1996, 39 (2-3) :209-220
[3]   Evaluation of the biological properties of soluble chitosan and chitosan microspheres [J].
CarrenoGomez, B ;
Duncan, R .
INTERNATIONAL JOURNAL OF PHARMACEUTICS, 1997, 148 (02) :231-240
[4]  
DANIELS JR, 1988, CANCER RES, V48, P2446
[5]  
Denkbas EB, 2000, J APPL POLYM SCI, V76, P1637, DOI 10.1002/(SICI)1097-4628(20000613)76:11<1637::AID-APP4>3.0.CO
[6]  
2-Q
[7]   In vivo behavior of poly(D,L)-lactide microspheres designed for chemoembolization [J].
Flandroy, P ;
Grandfils, C ;
Daenen, B ;
Snaps, F ;
Dondelinger, RF ;
Jerome, R ;
Bassleer, R ;
Heinen, E .
JOURNAL OF CONTROLLED RELEASE, 1997, 44 (2-3) :153-170
[8]   Protein release from alginate matrices [J].
Gombotz, WR ;
Wee, SF .
ADVANCED DRUG DELIVERY REVIEWS, 1998, 31 (03) :267-285
[9]   Embolization with polyhydroxybutyrate (PHB) microspheres:: In-vivo studies [J].
Kassab, AC ;
Piskin, E ;
Bilgiç, S ;
Denkbas, EB ;
Xu, K .
JOURNAL OF BIOACTIVE AND COMPATIBLE POLYMERS, 1999, 14 (04) :291-303
[10]  
KU C, 1995, ARTIF CELL BLOOD SUB, V23, P143